Books, Health, Medical, Research, Science

Book Review: A Silent Fire

THE FLAMES WITHIN

Intro: A fascinating primer explores the crucial role of inflammation in our bodies and how it can go awry. What you need to know about inflammation in the body

INFLAMMATION is a crucial tool of the body’s immune system. As the first line of defence against injury or invaders, it traps bacteria and viruses, heals wounds and signals to other cells for help. It results in symptoms such as pain and swelling. Once a threat is remedied, inflammation, along with its ensuing discomfort, disappears – or at least it should.

In her debut book A Silent Fire: The story of inflammation, diet and disease, gastroenterologist Shilpa Ravella explains how inflammatory responses can turn against us. Crucially, she shows how chronic inflammation plays a role in many common conditions such as heart disease and cancer, and why Western diets are at least partially to blame.

This primer sees Ravella start with some fascinating history, travelling all the way back to the 1st century, when Aulus Cornelius Celsus first described four of the five main signs of inflammation: pain, heat, redness and swelling. The fifth, a loss of function, was identified in the mid-1800s.

Ravella spends a lot of time examining the work of Victorian scientists, such as Élie Metchnikoff, who won a Nobel Prize in 1908 for discovering immune cells called phagocytes that engulf pathogens and particles. Eventually, she moves on to modern-day researchers like Charles Serhan, who helped identify molecules known as resolvins that turn off inflammation.

This lays a proper foundation for the book’s second section, which connects these discoveries to inflammation’s possible role in disease. Low levels of inflammation have been found in people with conditions such as cancer. While inflammation is a normal response to injury and disease, persistent inflammation is now being viewed as a potential cause of illness.

Ravella further speculates that inflammation can contribute to conditions like depression and Alzheimer’s disease, though as a responsible medical professional, she provides important caveats and stresses the need for more research.

The most damning evidence links inflammation to autoimmune conditions – which occur when the body damages its own cells – such as rheumatoid arthritis. Characterised by long-lasting, low levels of inflammation, these conditions increase susceptibility to other problems like bone loss, heart disease and kidney disease.

The book wraps up by detailing how factors like diet and exercise can contribute to inflammation as well as help dampen it. For many, this won’t be new, but what may be illuminating is Ravella’s explanation of lifestyle significance.

For instance, she devotes a whole chapter to the gut microbiome, describing how processed foods and animal products, like red meat and dairy, disrupt microbial composition, setting off a chain of events that leads to increased inflammation. She then explains why fruits, vegetables and whole grains can help undo these effects.

A Silent Fire is no quick read: it is packed with information, combining medical history, innovative research and first-hand clinical experiences. At times, it feels over-ambitious, as Ravella crams in as much as possible rather than clearly connecting the various topics. It can also be difficult to keep track of all the different microbes, scientists and immune cells involved, especially if you lack a scientific or medical background.

But Ravella’s writing style keeps even the most dense page engaging. She breathes life into biological function, at one point describing types of white blood cells as “sophisticated warriors” that “voraciously gobble up” particles. Ultimately, the book is perfect for those looking to delve deeper into the history and intricate workings of immunology, diet and disease.

– A Silent Fire is published by Bodley Head

– Rheumatoid arthritis, as shown in this X-ray, is a chronic inflammatory condition
Standard
Health, Research, Science, Society

Is commuting harming our health?

COMMUTING

Intro: Some 4 billion people are known to travel between home and work, school, or college. Is the daily commute just something people love to hate, or a major health hazard?

SOME FORM OF COMMUTING has been part of our daily lives since the Neolithic age, and although many complain about their journeys, research shows that we wouldn’t want it any other way. We’re generally happiest when we have at least some distance between where we sleep and relax, and where we spend the bulk of our day. However, there are limits. People perceive their commute as part of their job, but if it makes us unhappy, we’re more likely to quit – so much so that an extra 20 minutes’ commuting time can reduce job satisfaction by the same amount as a 20 per cent pay cut.

Length of journey is the major factor in commuting: in the morning, your body clock is winding up the brain and body – alertness and attention increases with each passing minute, and if you’re stuck in traffic or a broken-down train during this precious primetime, then the most productive part of your day could be lost in transit. A morning journey of 45 minutes or more seems to be the tipping point at which the journey length starts to take a toll on physical and mental health. Workers who travel over 90 minutes each day are less fit, weigh more, and have higher blood pressure, compared to those with a shorter travel time. Longer commutes are also linked to health issues such as sleep problems, exhaustion, aches and pains, and overeating. Moreover, unpredictable and stressful delays, the chances of which increase the longer your commute, make the biggest negative impact on our health.

The method of travel also plays a part in how healthy your commute is. Driving takes the cake as the most stressful and unhealthiest way to commute. Public transport always comes out better, but simply using your legs to get to work – be it walking, cycling, or jogging – beats both.

Scientists have shown that a “good” commute is one that is long enough to give us time to draw a psychological line between homelife and work – but not so long that it makes us anxious, bored, or tired. Even if you work from home, you can benefit from a “virtual” commute by going for a short walk, run, or cycle to mark the start and end of your working day.

Research suggests that 15 minutes is the optimum length of time for a commute.

Want To Improve Your Commute?

. WALK, JOG, OR CYCLE – moving under your own power releases mood-lifting hormones and increases blood flow to the brain, making you happier and more productive.

. SIMPLIFY JOURNEYS that involve more than one stop; for example taking children to school on the way to work. Multiple-stage trips are the most stressful.

. PLAN YOUR DAY and spend the time mentally adjusting to work mode on the way in, and winding down on the journey home.

. FIND A NEW JOB if your commute is more than 90 minutes long – your health is probably suffering!

Standard
Medical, Research, Science

Flu jab offers hope in fight against dementia

FLU VACCINE

Intro: Having vaccine for six years in a row cuts risk of developing incurable illness by 14%

HAVING the flu vaccine every winter could significantly reduce the risk of dementia, a study suggests.

The jab lowered the chances of developing the incurable condition by 14 per cent.

But the analysis by scientists says it seems to work only when patients have had it for at least six years in a row.

Researchers believe the vaccines – given to tens of millions in the UK last winter – gradually strengthen the ageing immune system to the point where it can prevent the underlying damage in the brain that causes dementia.

Britain faces an epidemic of Alzheimer’s disease and dementia because of an ageing population.

Alzheimer’s Scotland estimates that by 2031, there will be between 102,000 and 114,000 people in the country with dementia.

There has been no major breakthrough in treatment for decades – but now scientists believe vaccines such as the flu jab could play an important part in decreasing the surge in patients.

Researchers from Saint Louis University School of Medicine in the US tracked nearly 70,000 individuals aged 60 or over. They monitored how many had an annual flu vaccine and whether they subsequently developed dementia.

The findings, first published in the journal Vaccine, showed little difference between those who had received no jab and those immunised annually for the previous four or five years. But once they got to six years or more, the risk dropped by an average of 14 per cent. Scientists said there is no suggestion that catching flu causes dementia. Instead, the benefit comes from having a vaccine later in life.

Animal studies suggest vaccinations such as the one for flu increase the activity of immune system cells in the central nervous system that are responsible for repairing damage that can lead to dementia.

The study says: “Flu vaccines could be a cheap, low-risk intervention against dementia.”

A spokesperson for Alzheimer’s Research UK called the results intriguing, adding: “Understanding why this is the case is an important avenue for further research.”

Standard